Ciprofloxacin dimers target gyrase in Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 6, 2004, Pages 2108-2115

  Gould, Katherine A ^a   Pan, Xiao Su ^a   Kerns, Robert J ^b   Fisher, L Mark ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 LUTIDINYLCIPROFLOXACIN; BUTENYLCIPROFLOXACIN; CIPROFLOXACIN; DIMER; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; PIPEMIDIC ACID CIPROFLOXACIN DIMER; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; DNA CLEAVAGE; DRUG TARGETING; ENZYME ACTIVITY; GENE MUTATION; GYRA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARC GENE; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; CATALYSIS; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; NUCLEIC ACID CONFORMATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIAE;

EID: 2542501631     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.6.2108-2115.2004     Document Type: Article

References (32)

1. Adams, D. E., E. M. Shekman, E. L. Zechiedrich, M. B. Schmid, and N. R. Cozzarelli. 1992. The role of topoisomerase IV in partitioning DNA replicons and the structure of catenated intermediates in DNA replication. Cell 71:277-288.
2. Alovero, F. L., X.-S. Pan, J. E. Morris, R. H. Manzo, and L. M. Fisher. 2000. Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase. Antimicrob. Agents Chemother. 44:320-325.
3. Cullen, M. E., A. W. Wyke, R. Kuroda, and L. M. Fisher. 1989. Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones. Antimicrob. Agents Chemother. 33:886-894.
4. Drlica, K., and X. Zhao. 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61:377-392.
5. Ferrero, L., B. Cameron, B. Manse, D. Lagneux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol. Microbiol. 13:641-653.
6. Ferrero, L., B. Cameron, and J. Crouzet. 1995. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1554-1558.
7. Fisher, L. M., K. A. Gould, X.-S. Pan, S. Patel, and V. J. Heaton. 2003. Analysis of dual active fluoroquinolones in Streptococcus pneumoniae. J. Antimicrob. Chemother. 52:312-313.
8. Gellert, M., K. Mizuuchi, M. H. O'Dea, T. Itoh, and J.-I. Tomizawa. 1977. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc. Natl. Acad. Sci. USA 74:4772-4776.
9. Gellert, M., K. Mizuuchi, M. H. O'Dea, and H. A. Nash. 1976. DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc. Natl. Acad. Sci. USA 73:3872-3876.
10. Hiasa, H., D. O. Yousef, and K. J. Marians. 1996. DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex. J. Biol. Chem. 271:26424-26429.
11. Jones, R. N., and L. A. Mandell. 2002. Fluoroquinolones for the treatment of outpatient community-acquired pneumonia. Diagn. Microbiol. Infect. Dis. 44:69-76.
12. Kato, J., Y. Nishimura, R. Imamura, H. Niki, S. Higara, and H. Suzuki. 1990. New topoisomerase essential for chromosome segregation in E. coli. Cell 63:393-404.
13. Kerns, R. J., M. R. Rybak, G. W. Kaatz, F. Vaka, R. Cha, R. G. Gruz, and V. U. Diwadka. 2003. Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus. Bioorg. Med. Chem. Lett. 13:2109-2112.
14. Kerns, R. J., M. R. Rybak, G. W. Kaatz, F. Vaka, R. Cha, R. G. Gruz, V. U. Diwadkar, and T. D. Ward. 2003. Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus. Bioorg. Med. Chem. Lett. 13:1745-1749.
15. Mizuuchi, K., L. M. Fisher, M. H. O'Dea, and M. Gellert. 1980. DNA gyrase action involves the introduction of transient double strand breaks into DNA. Proc. Natl. Acad. Sci. USA 77:1847-1851.
16. Morais-Cabral, J. H., A. P. Jackson, C. V. Smith, N. Shikotra, A. Maxwell, and R. C. Liddington. 1997. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 388:903-906.
17. Munoz, R., and A. G. de la Campa. 1996. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of quinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob. Agents Chemother. 40:2252-2257.
18. Palu, G., S. Valisena, G. Ciarrochi, B. Gatto, and M. Palumbo. 1992. Quinolone binding to DNA is mediated by magnesium ions. Proc. Natl. Acad. Sci. USA 89:9671-9675.
19. Pan, X.-S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
20. Pan, X.-S., and L. M. Fisher. 1996. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J. Bacteriol. 178:4060-4069.
21. Pan, X.-S., and L. M. Fisher. 1997. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob. Agents Chemother. 41:471-474.
22. Pan, X.-S., and L. M. Fisher. 1998. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2810-2816.
23. Pan, X.-S., and L. M. Fisher. 1999. Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones. Antimicrob. Agents Chemother. 43:1129-1136.
24. Pan, X.-S., G. Yague, and L. M. Fisher. 2001. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins. Antimicrob. Agents Chemother. 45:3140-3147.
25. Shen, L. L., L. A. Mitscher, P. N. Sharma, T. J. O'Donnell, W. T. Chu, C. S. Cooper, T. Rosen, and A. G. Pernet. 1989. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a co-operative drug-DNA binding model. Biochemistry 28:3886-3894.
26. Takenouchi, T., F. Tabata, Y. Iwata, H. Hanzawa, M. Sugawara, and S. Ohya. 1996. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1835-1842.
27. Tornaletti, S., and A. M. Pedrini. 1988. Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments. Biochim. Biophys. Acta 949:279-287.
28. Wang, J. C. 1996. DNA topoisomerases. Annu. Rev. Biochem. 65:635-692.
29. Yague, G., J. E. Morris, X.-S. Pan, K. A. Gould, and L. M. Fisher. 2002. Cleavable complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones. Antimicrob. Agents Chemother. 46:413-419.
30. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.
31. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.
32. Zechiedrich, E. L., and N. R. Cozzarelli. 1995. Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication of Escherichia coli. Genes Dev. 9:2859-2869.